Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of cMET in Gastric Cancer—A Review of the Literature

26 Mar 2023

Abstract excerpt

Gastric cancer (GC) is an important cause of cancer worldwide with over one million new cases yearly. The vast majority of cases present in stage IV disease, and it still bears a poor prognosis. However, since 2010, progress has been made with the introduction of targeted therapies against HER2 and with checkpoint inhibitors (PDL1). More agents interfering with other targets (FGFR2B, CLDN18.2) are being...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Metastasis and carcinoma case studies
Share to Neuroendocrine Tumor Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37046637
DOI: 10.3390/cancers15071976

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of cMET in Gastric Cancer—A Review of the LiteraturePMID 37046637Read ↗

The prognostic and immune significance of KIF3C in pan-cancer and its relationship with malignant progression of gastric cancerSemantic proximity Read ↗

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.Semantic proximity Read ↗

Deregulation ofARID1A,CDH1,cMETandPIK3CAand target-related microRNA expression in gastric cancerSemantic proximity Read ↗

Identifying therapeutic targets in gastric cancer: the current status and future direction.Semantic proximity Read ↗

Integrated Evaluation of TRK Expression in Gastric Adenocarcinoma: Correlation with Immunohistochemistry- and In Situ Hybridization–Based Molecular Classification and Diagnostic ChallengesSemantic proximity Read ↗

Gastric cancer management: Kinases as a target therapySemantic proximity Read ↗

Forty‐nine gastric cancer cell lines with integrative genomic profiling for development of c‐MET inhibitorSemantic proximity Read ↗

METTL17 promotes gastric cancer progression by activating the Wnt/β-catenin signaling pathway through negative regulation of GSK-3βSemantic proximity Read ↗

KMT2D promotes proliferation of gastric cancer cells: evidence from ctDNA sequencingSemantic proximity Read ↗

Role of cMET in the Development and Progression of Colorectal CancerSemantic proximity Read ↗

PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis ResistanceSemantic proximity Read ↗

Status of CHEK2 and p53 in patients with early‑onset and conventional gastric cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.